Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Thierry Dantoine

Femme et Homme Max 99 ans
Thierry Dantoine MAJ Il y a 4 ans

Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment This is a prospective, multicenter, open-label study. Following screening and baseline assessments, eligible patients will be switched to rivastigmine and will enter the 16 week run-in riv...

Pays France
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations